Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
boston blog main
new york blog main
boston
boston top stories
cancer
clinical trials
national top stories
new york top stories
abcellera
alirocumab
alnylam pharmaceuticals
amgen
antibodies
azacitidine
beta-thalassemia
biology
codiak biosciences
coronavirus
covid-19
cutaneous t-cell lymphoma
dacogen
deals
decitabine
dna
drug discovery
drugs
eli lilly
epigenetics
epizyme
evercore isi
evolocumab
exosome
farydak
flagship pioneering
fulcrum therapeutics
heart attack
inclisiran
What
based
6
×
medicines
6
×
new
biotech
called
developing
investor
long
research
rna
treat
abcellera
abcellera’s
addition
aims
alderley
alltrna
alnylam
amadeus
announced
antibodies
antibody
approach
begin
betting
biologics
biosciences
bio’s
brings
bubbles
capital
catapult
cells
centre
cheshire
chief
cholesterol
class
clinical
codiak
Language
unset
Current search:
based
×
biotech
×
medicines
×
@tech.eu
1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
